Evogene Earnings Review: Q4 Summary
Benzinga Insights 8 months ago
Earnings
Evogene (NASDAQ:EVGN) reported its Q4 earnings results on Thursday, March 5, 2026 at 07:00 AM.
Here's what investors need to know about the announcement.
Earnings
Evogene missed estimated earnings by -134.62%, reporting an EPS of $-0.61 versus an estimate of $-0.26.
Revenue was down $1.30 million from the same period last year.
Earnings History Overview
Last quarter the company beat on EPS by $0.1 which was followed by a 4.63% increase in the share price the next day.
Here's a look at Evogene's past performance:
| Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|
| EPS Estimate | -0.41 | -0.63 | -0.50 | -0.73 |
| EPS Actual | -0.31 | -0.50 | -0.38 | 0.06 |
| Revenue Estimate | 650K | 930K | 4.42M | 3.62M |
| Revenue Actual | 312K | 884K | 2.44M | 1.61M |
To track all earnings releases for Evogene visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.